Beacon Pointe Advisors’s Anavex Life Sciences AVXL Stock Holding History

Beacon Pointe Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$70.6K	Hold	23,000	–	–	﹤0.01%	1801
2025 Q4	$81.9K	Hold	23,000	–	–	﹤0.01%	1473
2025 Q3	$205K	Hold	23,000	–	–	﹤0.01%	1315
2025 Q2	$212K	Hold	23,000	–	–	﹤0.01%	1172
2025 Q1	$197K	Hold	23,000	–	–	﹤0.01%	1157
2024 Q4	$247K	Hold	23,000	–	–	﹤0.01%	1080
2024 Q3	$131K	Hold	23,000	–	–	﹤0.01%	1185
2024 Q2	$97.1K	Buy	23,000 +5,000	+28%	+$20.2K	﹤0.01%	1229
2024 Q1	$91.6K	Hold	18,000	–	–	﹤0.01%	1313
2023 Q4	$168K	Sell	18,000 -225	-1%	-$1.55K	﹤0.01%	1249
2023 Q3	$119K	Buy	18,225 +225	+1%	+$1.79K	﹤0.01%	1270
2023 Q2	$146K	Hold	18,000	–	–	﹤0.01%	1031
2023 Q1	$154K	Hold	18,000	–	–	﹤0.01%	1086
2022 Q4	$167K	Hold	18,000	–	–	﹤0.01%	1005
2022 Q3	$186K	Hold	18,000	–	–	﹤0.01%	934
2022 Q2	$180K	Hold	18,000	–	–	﹤0.01%	977
2022 Q1	$222K	Sell	18,000 -225	-1%	-$2.77K	﹤0.01%	1087
2021 Q4	$316K	Hold	18,225	–	–	0.01%	713
2021 Q3	$327K	Hold	18,225	–	–	0.01%	673
2021 Q2	$417K	Hold	18,225	–	–	0.01%	546
2021 Q1	$272K	Hold	18,225	–	–	0.02%	407
2020 Q4	$98K	Buy	+18,225	New	+$96K	0.01%	495

Other funds holding AVXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Beacon Pointe Advisors's AVXL Position: Q1 2026 in Review

Beacon Pointe Advisors held its Anavex Life Sciences (AVXL) position steady in Q1 2026 at 23,000 shares worth $70.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1801.

Beacon Pointe Advisors first reported a position in AVXL in Q4 2020 and has held it in 22 quarters since. The position peaked at $417K in Q2 2021. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

Beacon Pointe Advisors held 23,000 shares of Anavex Life Sciences worth $70.6K as of Q1 2026.
Beacon Pointe Advisors left its Anavex Life Sciences share count unchanged in Q1 2026.
Anavex Life Sciences made up ﹤0.01% of Beacon Pointe Advisors's portfolio in Q1 2026, its #1801 holding.
Beacon Pointe Advisors first reported a position in Anavex Life Sciences in Q4 2020 and has held it in 22 quarters since.
Beacon Pointe Advisors's Anavex Life Sciences position peaked at $417K in Q2 2021.
190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Beacon Pointe Advisors's 13F filing for Q1 2026, filed 15 May 2026.